| Product NDC: | 42023-104 |
| Proprietary Name: | Aplisol |
| Non Proprietary Name: | tuberculin purified protein derivative |
| Active Ingredient(s): | 5 [iU]/.1mL & nbsp; tuberculin purified protein derivative |
| Administration Route(s): | INTRADERMAL |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42023-104 |
| Labeler Name: | JHP Pharmaceuticals LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA001781 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20080207 |
| Package NDC: | 42023-104-01 |
| Package Description: | 1 mL in 1 VIAL (42023-104-01) |
| NDC Code | 42023-104-01 |
| Proprietary Name | Aplisol |
| Package Description | 1 mL in 1 VIAL (42023-104-01) |
| Product NDC | 42023-104 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | tuberculin purified protein derivative |
| Dosage Form Name | INJECTION |
| Route Name | INTRADERMAL |
| Start Marketing Date | 20080207 |
| Marketing Category Name | BLA |
| Labeler Name | JHP Pharmaceuticals LLC |
| Substance Name | TUBERCULIN PURIFIED PROTEIN DERIVATIVE |
| Strength Number | 5 |
| Strength Unit | [iU]/.1mL |
| Pharmaceutical Classes | Skin Test Antigen [EPC],Tuberculosis Skin Test [EPC],Cell-mediated Immunity [PE],Antigens, Bacterial [Chemical/Ingredient] |